*001679939
*00520190709124708.0
*007ta
*008180911s2018    no a   e m    00  0 eng
*00901351nam a2200301 c 4500
*019  $bl
*020  $a978-82-8377-280-7$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920617226202201
*035  $a(NO-LaBS)15213358(bibid)
*040  $aNO-OsNB$bnob$ekatreg
*060 4$aWH 200
*08204$a616.994979$223/nor$qNO-OsNB
*1001 $aOei, Yi Sheng, Vincent$d1985-$0(NO-TrBIB)1560455409205$4aut$_96693600
*24510$aEngineering NK cells towards next generation NK cell immunotherapy$cVincent Oei Yi Sheng
*260  $aOslo$bUniversity of Oslo, Faculty of Medicine$c2018
*300  $a1 b. (flere pag.)$bill. (noen kol.)$c24 cm
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Oslo, 2018
*650 2$aImmunotherapy$0(DNLM)D007167$_12926300
*650 2$aKiller Cells, Natural$ximmunology$0(DNLM)D007694Q000276$_96693700
*650 2$aNK Cell Lectin-Like Receptor Subfamily C$ximmunology$0(DNLM)D055654Q000276$_96693800
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$_10213500
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919954483202202$b2021-11-14T20:41:17Z$z999919954483202202
^